The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma (Q34595043)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma
scientific article

    Statements

    The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma (English)
    0 references
    Morton Coleman
    Michael W Schuster
    David Irwin
    Anthony L Boral

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit